We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (MelaViD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01264874
Recruitment Status : Terminated (poor accrual rate)
First Posted : December 22, 2010
Last Update Posted : January 31, 2018
Information provided by (Responsible Party):
European Institute of Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2017
  Study Completion Date : July 2017